4.6 Article

Cdc25A promotes cell survival by stimulating NF-κB activity through IκB-α phosphorylation and destabilization

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2012.02.152

Keywords

Cdc25A; NF-kappa B; I kappa-B alpha; Ubiquitination; Apoptosis

Funding

  1. National Research Foundation of Korea(NRF)
  2. Ministry of Education, Science and Technology [2009-0072203]
  3. National Research Foundation of Korea [2009-0072203] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Cell division cycle 25A (Cdc25A), a dual specificity protein phosphatase, exhibits anti-apoptotic activity, but the underlying molecular mechanisms are poorly characterized. Here we report that Cdc25A inhibits cisplatin-induced apoptotic cell death by stimulating nuclear factor-kappa B (NF-kappa B) activity. In HEK-293 cells, Cdc25A decreased protein level of inhibitor subunit kappa B alpha (I kappa-B alpha) in association with increased serine 32-phosphorylation, followed by stimulation of transcriptional activity of NF-kappa B. Inhibition of NF-kappa B activity by chemical inhibitor or overexpression of I kappa-B alpha in Cdc25A-elevated cancer cells resistant to cisplatin improved their sensitivity to cisplatin-induced apoptosis. Our data show for the first time that Cdc25A has an important physiological role in NF-kappa B activity regulation and it may be an important survival mechanism of cancer cells. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available